Cargando…

Drug delivery of 6-bromoindirubin-3’-glycerol-oxime ether employing poly(d,l-lactide-co-glycolide)-based nanoencapsulation techniques with sustainable solvents

BACKGROUND: Insufficient solubility and stability of bioactive small molecules as well as poor biocompatibility may cause low bioavailability and are common obstacles in drug development. One example of such problematic molecules is 6-bromoindirubin-3'-glycerol-oxime ether (6BIGOE), a hydrophob...

Descripción completa

Detalles Bibliográficos
Autores principales:	Czapka, Anna, Grune, Christian, Schädel, Patrick, Bachmann, Vivien, Scheuer, Karl, Dirauf, Michael, Weber, Christine, Skaltsounis, Alexios-Leandros, Jandt, Klaus D., Schubert, Ulrich S., Fischer, Dagmar, Werz, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725458/ https://www.ncbi.nlm.nih.gov/pubmed/34983538 http://dx.doi.org/10.1186/s12951-021-01179-7

Ejemplares similares

The Indirubin Derivative 6-Bromoindirubin-3′-Oxime Activates Proteostatic Modules, Reprograms Cellular Bioenergetic Pathways, and Exerts Antiaging Effects
por: Tsakiri, Eleni N., et al.
Publicado: (2017)

Nanoencapsulation of sophorolipids in PEGylated poly(lactide-co-glycolide) as a novel approach to target colon carcinoma in the murine model
por: Haggag, Yusuf, et al.
Publicado: (2020)

6-Bromoindirubin-3’-oxime (6BIO) prevents myocardium from aging by inducing autophagy
por: Guo, Donghao, et al.
Publicado: (2020)

Influence of Radiation Sterilization on Properties of Biodegradable Lactide/Glycolide/Trimethylene Carbonate and Lactide/Glycolide/ε-caprolactone Porous Scaffolds with Shape Memory Behavior
por: Rychter, Piotr, et al.
Publicado: (2016)

Induction of atypical cell death in thyroid carcinoma cells by the indirubin derivative 7-bromoindirubin-3′-oxime (7BIO)
por: Broecker-Preuss, Martina, et al.
Publicado: (2015)

Effect of nanoencapsulation on the phenomenon of drug interaction between anti-M.avium drug, rifabutin and anti-HIV drug, ritonavir by employing poly (lactide-co-glycolide) nanoparticles
por: Grewal, Tapinder, et al.
Publicado: (2012)

A novel 7-bromoindirubin with potent anticancer activity suppresses survival of human melanoma cells associated with inhibition of STAT3 and Akt signaling
por: Liu, Lucy, et al.
Publicado: (2012)

The Design of Poly(lactide-co-glycolide) Nanocarriers for Medical Applications
por: Essa, Divesha, et al.
Publicado: (2020)

Triple-Shape Memory Behavior of Modified Lactide/Glycolide Copolymers
por: Smola-Dmochowska, Anna, et al.
Publicado: (2020)

A Dual-sensitive Hydrogel Based on Poly(Lactide-co-Glycolide)-Polyethylene Glycol-Poly(Lactide-co-Glycolide) Block Copolymers for 3D Printing
por: Zhou, Yang, et al.
Publicado: (2021)

Indirubin Derivative 7-Bromoindirubin-3-Oxime (7Bio) Attenuates Aβ Oligomer-Induced Cognitive Impairments in Mice
por: Chen, Liping, et al.
Publicado: (2017)

BIO (6-bromoindirubin-3′-oxime) GSK3 inhibitor induces dopaminergic differentiation of human immortalized RenVm cells
por: Soleimani, Mitra, et al.
Publicado: (2018)

6-Bromoindirubin-3′-Oxime Regulates Colony Formation, Apoptosis, and Odonto/Osteogenic Differentiation in Human Dental Pulp Stem Cells
por: Kornsuthisopon, Chatvadee, et al.
Publicado: (2022)

GSK3 inhibitors CHIR99021 and 6-bromoindirubin-3′-oxime inhibit microRNA maturation in mouse embryonic stem cells
por: Wu, Yongyan, et al.
Publicado: (2015)

Imparting Superhydrophobicity to Biodegradable Poly(lactide-co-glycolide) Electrospun Meshes
por: Kaplan, Jonah A., et al.
Publicado: (2014)

6-bromo-indirubin-3′-oxime (6BIO), a Glycogen synthase kinase-3β inhibitor, activates cytoprotective cellular modules and suppresses cellular senescence-mediated biomolecular damage in human fibroblasts
por: Sklirou, Aimilia D., et al.
Publicado: (2017)

Biodegradable membrane of poly(l-lactide acid-dioxanone-glycolide) and stereocomplex poly(lactide) with enhanced crystallization and biocompatibility
por: Fan, Tiantang, et al.
Publicado: (2022)

6-Bromoindirubin-3′-Oxime (6BIO) Suppresses the mTOR Pathway, Promotes Autophagy, and Exerts Anti-aging Effects in Rodent Liver
por: Guo, Donghao, et al.
Publicado: (2019)

Synthesis and In Vitro Antitumor Activity of Naringenin Oxime and Oxime Ether Derivatives
por: Latif, Ahmed Dhahir, et al.
Publicado: (2019)

Poly(lactide-co-glycolide)/Hydroxyapatite Porous Scaffold with Microchannels for Bone Regeneration
por: Zhang, Ning, et al.
Publicado: (2016)

In vitro–in vivo correlation from lactide-co-glycolide polymeric dosage forms
por: D’Souza, Susan, et al.
Publicado: (2014)

Microencapsulation of Thymol in Poly(lactide-co-glycolide) (PLGA): Physical and Antibacterial Properties
por: Zhu, Zhu, et al.
Publicado: (2019)

Biocompatible Composite Materials Based on Porous Hydroxyapatite Ceramics and Copolymer of Lactide and Glycolide
por: Lytkina, Daria, et al.
Publicado: (2021)

6-Bromoindirubin-3′-oxime intercepts GSK3 signaling to promote and enhance skeletal muscle differentiation affecting miR-206 expression in mice
por: Ragozzino, Elvira, et al.
Publicado: (2019)

Comparison of Closure of Gastric Perforation Ulcers With Biodegradable Lactide-Glycolide-Caprolactone or Omental Patches
por: Bertleff, Marietta J. O. E., et al.
Publicado: (2009)

Enhanced antibacterial activity of roxithromycin loaded pegylated poly lactide-co-glycolide nanoparticles
por: Koopaei, Mona Noori, et al.
Publicado: (2012)

Rational Mitomycin Nanocarriers Based on Hydrophobically Functionalized Polyelectrolytes and Poly(lactide-co-glycolide)
por: Lamch, Łukasz, et al.
Publicado: (2022)

Functionalized Cyclopentenones and an Oxime Ether as Antimicrobial Agents
por: Gomes, Rafael F. A., et al.
Publicado: (2021)

A Review of Biologically Active Oxime Ethers
por: Kosmalski, Tomasz, et al.
Publicado: (2023)

Influence of Hydroxyapatite Surface Functionalization on Thermal and Biological Properties of Poly(l-Lactide)- and Poly(l-Lactide-co-Glycolide)-Based Composites
por: Gazińska, Małgorzata, et al.
Publicado: (2020)

Double-Walled Poly-(D,L-lactide-co-glycolide) (PLGA) and Poly(L-lactide) (PLLA) Nanoparticles for the Sustained Release of Doxorubicin
por: Cardoso, M. Margarida, et al.
Publicado: (2021)

Short-Term Caloric Restriction and Subsequent Re-Feeding Compromise Liver Health and Associated Lipid Mediator Signaling in Aged Mice
por: Schädel, Patrick, et al.
Publicado: (2023)

Metabololipidomic and proteomic profiling reveals aberrant macrophage activation and interrelated immunomodulatory mediator release during aging
por: Schädel, Patrick, et al.
Publicado: (2023)

Publisher Correction: 6-Bromoindirubin-3′-oxime intercepts GSK3 signaling to promote and enhance skeletal muscle differentiation affecting miR-206 expression in mice
por: Ragozzino, Elvira, et al.
Publicado: (2020)

Preparation and Characterization of Poly(D,L-Lactide-co-Glycolide) Nanoparticles Containing Ascorbic Acid
por: Stevanović, Magdalena M., et al.
Publicado: (2007)

Poly(d,l-lactide-co-glycolide)–chitosan composite particles for the treatment of lung cancer
por: Arya, Neha, et al.
Publicado: (2015)

Glycosaminoglycan-functionalized poly-lactide-co-glycolide nanoparticles: synthesis, characterization, cytocompatibility, and cellular uptake
por: Lamichhane, Surya P, et al.
Publicado: (2015)

Preparation, characterization, and safety evaluation of poly(lactide-co-glycolide) nanoparticles for protein delivery into macrophages
por: Guedj, Anne-Sophie, et al.
Publicado: (2015)

Preparation, Characterization, and In Vivo Evaluation of Olanzapine Poly(D,L-lactide-co-glycolide) Microspheres
por: D'Souza, Susan, et al.
Publicado: (2013)

Controlled Release of Lysozyme from Double-Walled Poly(Lactide-Co-Glycolide) (PLGA) Microspheres
por: Ansary, Rezaul H., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fhnaijkvhmtpejhp4ik9leuv6u